Alex Sapir
CEO and President
Replay available
Fulcrum Therapeutics, Inc. (FULC) Q4 2024 Earnings Call
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) Q4 2024 earnings conference call, held 2025-02-26. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Alan Musil
Chief Financial Officer
Dr. Ian Frazier
Senior Vice President of Early Development
Rick Miller
Investor (asking on behalf of Kristin Kluska, Cancer Fitzgerald)
Joe Schwartz
Investor (Living Partners)
Matthew Bigler
Investor (Oppenheimer)
Jeremiah Laurenton
Investor (asking on behalf of Tasin Hamad, Bank of America Securities)
Edward Tenthoff
Investor (Piper Sandler)
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Fulcrum Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.638 Good morning and welcome to Full Chrome Therapeutics fourth quarter and full year 2024 00:00:04.638 -- 00:00:08.044 financial results and business update conference call. 00:00:08.044 -- 00:00:11.349 Currently all participants are in listen-only mode. 00:00:11.349 -- 00:00:16.397 This call is being webcast live and can be accessed on the investor section of Full Chrome's 00:00:16.397 -- 00:00:19.258 website at www.fullchrometx.com 00:00:20.663 -- 00:00:25.659 and is being recorded. Please be reminded that remarks during this call may contain forward-looking 00:00:25.659 -- 00:00:30.985 statements within the meaning of Private Securities Litigation Reform Act of 1995, 00:00:30.985 -- 00:00:36.030 may include statements about the company's future expectations and plans, clinical development 00:00:36.030 -- 00:00:38.994 timelines, and financial projections. 00:00:38.994 -- 00:00:43.479 While these forward-looking statements represent Fulcrum's views as of today, this should 00:00:43.479 -- 00:00:48.064 not be relied upon as representing the company's views in the future. 00:00:48.064 -- 00:00:53.606 Fulcrum may update these statements in the future because not taking on and any applications 00:00:53.606 -- 00:00:58.547 to do so. These refer to Wilkrom's most recent filings with the Securities and Exchange 00:00:58.547 -- 00:01:02.711 Commission for discussions of certain risks and uncertainties associated with the company's 00:01:02.711 -- 00:01:08.558 business. Leading the call today will be Alex Sapir, CEO and President of Wilkrom. 00:01:08.558 -- 00:01:13.543 Joining Alex on the call are Alan Musil, Chief Financial Officer, and Dr. 00:01:13.543 -- 00:01:18.088 Ian Frazier, Senior Vice President of Early Development. 00:01:18.088 --...